Presenting
Promotions
on 3 exciting
Dechra
products!
Vetivex®
Dechra's 1000 mL cases of Vetivex® Veterinary Fluids have changed from 12 bags/case to 14 bags/case.
To celebrate this change, we’re giving you 2 bags for FREE* through March 31, 2024!*
Buy 12 bags of Vetivex® 1000 mL fluids, receive 2 bags FREE.*
Dechra offers a variety of veterinary fluids with their Vetivex® line, including Lactated Ringer’s Injection, Lactated Ringer’s and 5% Dextrose Injection, Hypertonic Saline Solution 7.2%, 0.9% Sodium Chloride Injection, and pHyLyte® Injection pH 7.4 (multiple electrolytes injection, Type 1, USP).
Zenalpha®
(medetomidine and vatinoxan hydrochlorides injection)
Buy 2 vials of Zenalpha®, receive 1 vial FREE.**
Zenalpha® is an innovative, alpha-2 combination drug for use as a sedative and analgesic in dogs to facilitate clinical examinations, clinical procedures and minor surgical procedures. Not intended for use in cats.
- Helps improve the sedation experience from start to finish
- Effective in a broad range of procedures
- For intramuscular (IM) injection in dogs only
Laverdia®-CA1
(verdinexor tablets)
Buy 1 bottle of 2.5 mg 50 ct and 1 bottle 10 mg 50 ct Laverdia®-CA1, receive 1 bottle 50 mg 16 ct FREE.**
Laverdia®-CA1 is FDA conditionally approved to treat lymphoma in dogs.
- Kills cancer cells at the nuclear core, generally sparing healthy cells1
- Twice weekly at-home oral administration
- Priced to expand your options and treat more patients
What does conditional approval mean?
For a veterinary drug to receive conditional approval, it must be shown to be safe when used according to the label. It must also demonstrate a “reasonable expectation of effectiveness,” but has not yet proven that it meets the “substantial evidence” standard of effectiveness for full approval. While a drug is conditionally approved it is not to be used for any off-label species or indications.
Zenalpha® Important Safety Information
As with all drugs, side effects may occur. For use in dogs only. Not intended for use in cats. Not for use in humans. Avoid skin, eye or mucosal contact. In case of accidental oral intake or self-injection, seek medical advice immediately and show the package insert to the physician. DO NOT DRIVE as sedation, loss of consciousness, and changes in blood pressure may occur. People with cardiovascular disease and pregnant women should exercise special caution to avoid exposure. Uterine contractions and decreased fetal blood pressure may occur after accidental systemic exposure. Do not use Zenalpha in dogs with cardiac disease, respiratory disorders, shock, severe debilitation, that have hypoglycemia or are at risk of developing hypoglycemia, or are stressed due to extreme heat, cold or fatigue. Zenalpha should not be administered in the presence of pre-existing hypotension, hypoxia or bradycardia. Due to the pronounced cardiovascular effects of alpha2-adrenoceptor agonists, only clinically healthy dogs (American Society of Anesthesiologists [ASA] classes I and II) should be administered Zenalpha. Dogs should be monitored frequently during sedation for changes in heart rate, blood pressure, respiratory rate and body temperature. Tachycardia may occur in some dogs after recovery from sedation. The following adverse reactions have been reported: diarrhea, muscle tremors and colitis. Refer to the prescribing information for complete details or visit www.dechra-us.com.
Laverdia®-CA1 Important Safety Information
For use in dogs only. Laverdia-CA1 (verdinexor tablets) is conditionally approved for the treatment of lymphoma in dogs. NOT FOR USE IN HUMANS. KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. CHILDREN SHOULD NOT COME INTO CONTACT WITH Laverdia-CA1. Pregnant women, women who may become pregnant, nursing women and children should not handle or administer Laverdia-CA1 or come into contact with the feces, urine, saliva, or vomit of treated dogs for 3 days following treatment. Laverdia-CA1 can affect male fertility based on animal studies and studies in humans. Wear protective disposable chemotherapy resistant gloves when handling Laverdia-CA1 to avoid direct exposure to moistened, broken or crushed tablets or biological waste from the treated dog (feces, urine, saliva, or vomit). Do not use in dogs that are pregnant, lactating or intended for breeding. Laverdia-CA1 is a possible teratogen and can affect female and male fertility. Dogs should be frequently monitored for hematologic and serum chemistry abnormalities. The most commonly reported adverse reactions in dogs include anorexia, weight loss, vomiting, diarrhea, lethargy, polyuria, polydipsia, elevated liver enzymes and thrombocytopenia. Please see package insert or visit dechra-us.com for full prescribing information.
† 2021-2023 Market Share Data on File
1. Etchin J, Sun Q, Kentsis A, Farmer A, Zhang ZC, et al. (2013) Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells. Leukemia 27: 66-74
*Free goods must be the same fluid purchased. Unless otherwise indicated, all qualifying Dechra Veterinary Products must be purchased on a single invoice and the free goods must be shipped with the qualifying purchases. When ordering 1 case (14 bags); you’ll be charged for 12 bags and receive 2 bags free. Free goods will be the value of lowest priced product purchased. Place your order with your distributor and reference the “Vetivex Buy 12 Get 2 Free promotion.” Distributor will ship free goods. Dechra reserves the right to not supply free goods unless a Veterinarian-Client-Patient Relationship (VCPR) can be clearly demonstrated. Valid for US Veterinarians only. Offer valid until March 31, 2024. Dechra has the right to modify or cancel the terms of this promotion at any time upon written notice. Promotions will not be honored on back orders or out of stock items. Prices are subject to change without prior notice. Offers cannot be combined. For questions, please email us.promotions@dechra.com.
**Unless otherwise indicated, all qualifying Dechra Veterinary Products must be purchased on a single invoice and the free goods must be shipped with the qualifying purchases. Free goods will be the value of lowest priced product purchased. Place your order with your distributor and reference the “Dechra 1/14-3/31 Promotion.” Distributor will ship free goods. Dechra reserves the right to not supply free goods unless a Veterinarian-Client-Patient Relationship (VCPR) can be clearly demonstrated. Valid for US Veterinarians only. Offer valid January 14 – March 31, 2024. Dechra has the right to modify or cancel the terms of this promotion at any time upon written notice. Promotions will not be honored on back orders or out of stock items. Prices are subject to change without prior notice. Offers cannot be combined. For questions, please email us.promotions@dechra.com.
C240093